Year 2019 / Volume 111 / Number 11
Original
Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer

839-845

DOI: 10.17235/reed.2019.6201/2019

Bo Yuan, Jing Fu, Wen-Long Yu, Xiao-Hui Fu, Ying-He Qiu, Lei Yin, Bin Zhu, Yong-Jie Zhang,

Abstract
Objectives: the aim of this study was to evaluate the prognostic significance of preoperative serum lipid in patients with gallbladder cancer (GBC). Methods: ninety-nine patients with GBC between October 2009 and December 2013 were reviewed in this retrospective study. Total serum cholesterol (TC), total triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein A (Apo-A), apolipoprotein B (Apo-B) and free fatty acids (FFA) were measured before surgery. The correlation of serum lipid levels with clinical data, including gender, age, tumor size, lymph nodes metastasis, tumor differentiation, distant metastasis and TNM stage were analyzed by univariate and multivariate survival analysis to evaluate independent prognostic factors. Results: compared with the normal HDL-C group (n = 57), the overall survival rate among GBC patients with low HDL-C levels (n = 42) was reduced (p < 0.05). However, there were no significant differences in overall survival for patients with different levels of TC, TG, Apo-A, Apo-B, LDL-C or FFA. The serum level of HDL-C was associated with TNM stage (p < 0.05) and distant metastasis (p < 0.001). The multivariate prognosis analysis showed that HDL-C and lymph nodes metastasis were independent prognostic factors (p < 0.05). A prognostic evaluation model based on HDL-C and lymph nodes metastasis was established. Conclusion: preoperative serum HDL-C level was closely associated with distant metastasis of patients with GBC. HDL-C level may be a valuable prognostic factor for GBC patients. The combination of HDLC and lymph nodes metastasis can better predict the prognosis of GBC.
Share Button
New comment
Comments
No comments for this article
References
1. Justo I, Marcacuzco A, Nutu OA, et al. A retrospective analysis of patients with gallbladder cancer: surgical treatment and survival according to tumor stage. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 2018;110(8):485-492. DOI: 10.17235/reed.2018.5435/2017
2. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clinical epidemiology 2014;6:99-109. DOI:10.2147/CLEP.S37357
3. Tuo JY, Zhang M, Zheng RS, et al. [Report of incidence and mortality of gallbladder cancer in China, 2014]. Zhonghua zhong liu za zhi.2018;40(12):894-899.doi: 10.3760/cma.j.issn.0253-3766.2018.12.004
4. Are C, Ahmad H, Ravipati A, et al. Global epidemiological trends and variations in the burden of gallbladder cancer. Journal of surgical oncology 2017;115(5):580-590. DOI:10.1002/jso.24546
5. Kim SH, Jung D, Ahn JH, et al. Differentiation between gallbladder cancer with acute cholecystitis: Considerations for surgeons during emergency cholecystectomy, a cohort study. International journal of surgery 2017;45:1-7. DOI:10.1016/j.ijsu.2017.07.046
6. Lee JW, Kim YT, Lee SH, et al. Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy. Gut and liver 2018;12(1):102-110. DOI:10.5009/gnl16588
7. Muntoni S, Atzori L, Mereu R, et al. Serum lipoproteins and cancer. Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(3):218-25. DOI:10.1016/j.numecd.2008.06.002
8. Yang Z, Qin W, Chen Y, et al. Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts. Cancer letters 2018;429:66-77. DOI:10.1016/j.canlet.2018.04.038
9. Li X, Tang H, Wang J, et al. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer. Breast 2017;32:1-6. DOI:10.1016/j.breast.2016.11.024
10. Mao M, Wang X, Sheng H, et al. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients. BMC cancer 2018;18(1):1178. DOI:10.1186/s12885-018-5028-8
11. Nagao M, Nakajima H, Toh R, et al. Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action. Journal of atherosclerosis and thrombosis 2018;25(10):985-993. DOI:10.5551/jat.RV17025
12. Bergquist JR, Shah HN, Habermann EB, et al. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study). International journal of surgery 2018;52:171-179. DOI:10.1016/j.ijsu.2018.02.052
13. Jiang SS, Weng DS, Jiang L, et al. The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. Journal of Cancer 2016;7(6):626-32. DOI:10.7150/jca.13837
14. Liu YY, Lin SJ, Chen YY, et al. High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma. Oncotarget 2016;7(28):42978-42987. DOI:10.18632/oncotarget.7160
15. Fang BA, Kovacevic Z, Park KC, et al. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy. Biochimica et biophysica acta 2014;1845(1):1-19. DOI:10.1016/j.bbcan.2013.11.002
16. Nishio S, Ushijima K, Tsuda N, et al. Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer letters 2008;264(1):36-43. DOI:10.1016/j.canlet.2008.01.020
17. Kawahara A, Akiba J, Hattori S, et al. Nuclear expression of N-myc downstream regulated gene 1/Ca(2+)-associated protein 43 is closely correlated with tumor angiogenesis and poor survival in patients with gastric cancer. Experimental and therapeutic medicine 2011;2(3):471-479. DOI:10.3892/etm.2011.222
18. Zhang SB, Song SP, Li B, et al. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome. Medical oncology 2012;29(3):1866-72. DOI:10.1007/s12032-011-0017-7
19. Hunter M, Angelicheva D, Tournev I, et al. NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24. Biochemical and biophysical research communications 2005;332(4):982-92. DOI:10.1016/j.bbrc.2005.05.050
20. Pirro M, Ricciuti B, Rader DJ, et al. High density lipoprotein cholesterol and cancer: Marker or causative? Progress in lipid research 2018;71:54-69. DOI:10.1016/j.plipres.2018.06.001
21. Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis 2016;5:e189. DOI:10.1038/oncsis.2015.49
Related articles

Original

Can we optimize CEA as a response marker in rectal cancer?

DOI: 10.17235/reed.2020.7321/2020

Editorial

The right colon challenge

DOI: 10.17235/reed.2018.5544/2018

Letter to the Editor

Neuroendocrine tumors of the pancreas: keys issues in dealing with heterogeneity

DOI: 10.17235/reed.2017.4997/2017

Letter to the Editor

Pancreatic neuroendocrine tumors. Prognostic factors

DOI: 10.17235/reed.2017.5109/2017

Editorial

Pancreas neuroendocrine tumors - not so rare or benign

DOI: 10.17235/reed.2016.4672/2016

Case Report

Hemobilia due to intracholecystic papillary neoplasm

DOI: 10.17235/reed.2016.4205/2016

Citation tools
Yuan B, Fu J, Yu W, Fu X, Qiu Y, Yin L, et all. Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer. 6201/2019


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 458 visits.
This article has been downloaded 133 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 30/01/2019

Accepted: 26/04/2019

Online First: 09/10/2019

Published: 07/11/2019

Article revision time: 80 days

Article Online First time: 252 days

Article editing time: 281 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology